As of Sep 01
| +0.08 / +4.71%|
The 3 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 3.00, with a high estimate of 5.80 and a low estimate of 2.50. The median estimate represents a +68.54% increase from the last price of 1.78.
The current consensus among 3 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.